Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03042832 · ClinicalTrials.gov registry record · NA
Testing the Leadership and Organizational Change for Implementation (LOCI) Intervention
A NA study of Substance Use Disorder and Mental Health Disorder, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 448
- Enrollment target
- 1
- Study location
NCT03042832: Completed NA study of Substance Use Disorder and Mental Health Disorder, sponsored by University of California, San Diego.
NCT03042832 is a NA study of Substance Use Disorder and Mental Health Disorder that has completed, run by University of California, San Diego. The registered enrollment target is 448 participants, below the 797-participant average among 18 other Substance Use Disorder trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03042832, a NA study of Substance Use Disorder and Mental Health Disorder, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 448 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the effects of the Leadership and Organizational Change for Implementation (LOCI) intervention in facilitating evidence-based practice (EBP) implementation in substance use disorder (SUD) and HIV services settings. LOCI improves implementation leadership and organizational support to develop strategic climate for EBP implementation. Greater efficiency and effectiveness of EBP implementation will improve the public health impact of evidence-based health and allied healthcare innovations and lead to greater effectiveness of SUD and HIV services. Project Terms:
Primary Outcome
The Implementation Leadership Scale (ILS: Aarons et al., 2014) is a brief 12-item measure with four subscales: Proactive Leadership, Knowledgeable Leadership, Supportive Leadership, and Perseverant Leadership. This measure will be included in the survey for providers, workgroup supervisors, and managers/executives. Data will be aggregated at the workgroup level.
Conditions Studied
Interventions
- BEHAVIORAL LOCI
- BEHAVIORAL Internet Based Webinar Leadership Training
Study Locations (1)
California
- UC San Diego - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 448 participants |
| Start Date | 2015-09-30 |
| Est. Completion | 2021-05-31 |
| Phase | NA |
What the finished NCT03042832 record still lists
NCT03042832 is an interventional study that assigns participants to a tested intervention. The registered 448 participants enrollment target is mid-sized for trials with a published cap, below the 797-participant average among 18 other Substance Use Disorder trials with a reported enrollment target (44% lower).
The record links to 2 conditions, with Substance Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which LOCI is the first listed.
NCT03042832 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03042832 about?
NCT03042832 is a clinical study titled "Testing the Leadership and Organizational Change for Implementation (LOCI) Intervention". This study will test the effects of the Leadership and Organizational Change for Implementation (LOCI) intervention in facilitating evidence-based practice (EBP) implementation in substance use disorder (SUD) and HIV services settings. LOCI improves implementation leadership and organizational suppo...
What is the current status of trial NCT03042832?
This trial is currently completed. It is a NA study. The enrollment target is 448 participants. The study started on 2015-09-30. Estimated completion is 2021-05-31.
What conditions does trial NCT03042832 study?
This clinical trial studies the following conditions: Substance Use Disorder, Mental Health Disorder.
What interventions are being tested in trial NCT03042832?
The interventions under investigation include: LOCI (BEHAVIORAL), Internet Based Webinar Leadership Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT03042832?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03042832 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03042832's enrollment target sits among peer trials
448 4th of 18 higher than 15 of 18 other Substance Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Smoking Cessation CM for Veterans With or at Risk for Cancer
RECRUITING · NA
-
A Type I Hybrid Effectiveness-Implementation Trial of MIO
RECRUITING · NA
-
OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
RECRUITING · NA
-
Personalized Approach to Healthy Use and Recovery (PATH) Trial
RECRUITING · NA
-
Defining Neurobiological Links Between Substance Use and Mental Illness
RECRUITING · NA
-
Successful Transitions and Reintegration Tools for Veterans (START-VETS)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06702449 · 448 participants · Phase 1
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
- NCT07125053 · 448 participants · NA
COPD Resources, Education, and Activity Designed for You Study
- NCT04065399 · 447 participants · Phase 1
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI